Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study-Reference-Cited by-同舟云学术

Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study

Published:2022-07-01 Issue:4 Volume:44 Page:966-974
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Mohan Anjana,Majd Zahra,Trinh Trang,Paranjpe Rutugandha,Abughosh Susan M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-022-01417-4.pdf

Reference37 articles.

1. Borne RT, O’Donnell C, Turakhia MP, et al. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration. BMC Cardiovasc Disord. 2017;17(1):236.

2. Koziel M, Teutsch C, Halperin JL, et al. Atrial fibrillation and comorbidities: clinical characteristics and antithrombotic treatment in GLORIA-AF. PLoS ONE. 2021;16(4): e0249524.

3. LaMori JC, Mody SH, Gross HJ, et al. Burden of comorbidities among patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2013;7(2):53–62.

4. Polovina M, Hindricks G, Maggioni A, et al. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation. Eur Heart J. 2018;39(45):4030–9.

5. Proietti M, Marzona I, Vannini T, et al. Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use. Mayo Clin Proc. 2019;94(12):2427–36.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States;Expert Review of Pharmacoeconomics & Outcomes Research;2024-09-03

2. Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence;International Journal of Clinical Pharmacy;2024-08-27

3. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation;Journal of Managed Care & Specialty Pharmacy;2024-05

4. Group-Based Trajectory Modeling to Identify Adherence Patterns for Direct Oral Anticoagulants in Medicare Beneficiaries with Atrial Fibrillation;2024-02-13

5. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios;Journal of Clinical Medicine;2023-09-13